Advertisement
BRKR or MTD or WAT
Which Stock Would AI Choose? Bruker Corporation (BRKR) vs. Mettler-Toledo International Inc. (MTD) vs. Waters Corporation (WAT) Stock Comparison
Key Takeaways
- BRKR offers value with a forward P/E (price-to-earnings ratio) of 15.22, significantly below peers, amid recent product launches boosting sentiment.
- MTD demonstrates stability with a market cap of $25.6B and YTD return around -9%, supported by strong analyst targets averaging $1,488.
- WAT leads in market cap at $30B with YTD gains near 19%, but faces earnings scrutiny ahead of its Q1 report.
- All three stocks in the scientific instruments sector have shown resilience with positive analyst outlooks, averaging 25% upside potential from current levels.
- Recent weeks feature innovation-driven momentum for BRKR, while MTD and WAT exhibit steadier relative performance amid sector volatility.
Introduction
Bruker Corporation (BRKR), Mettler-Toledo International Inc. (MTD), and Waters Corporation (WAT) are leading players in the scientific instruments sector, providing essential tools for life sciences, pharmaceuticals, and industrial applications. This comparison analyzes their recent market positioning, performance trends, and growth drivers, aiding traders seeking short-term opportunities and investors evaluating long-term stability in a sector buoyed by biopharma demand yet challenged by economic pressures. With upcoming earnings and innovation catalysts, understanding their relative strengths helps navigate current market dynamics.
BRKR Overview and Recent Performance
Bruker Corporation develops and distributes scientific instruments, including mass spectrometry, NMR (nuclear magnetic resonance), and imaging solutions for life sciences and materials research. In recent market activity, BRKR shares traded around $36.79, reflecting YTD gains of 21.79% amid volatility. Sentiment has improved with product unveilings like the MyGenius PRO molecular diagnostics system and expansions in spatial biology workflows at conferences such as AACR and ESCMID. Q4 2025 revenue reached $977.2M, though EPS of $0.59 missed estimates. Analyst targets average $46.79, signaling potential upside, driven by biopharma tools demand but tempered by prior earnings misses.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. specializes in precision instruments like laboratory balances, pipettes, and industrial weighing solutions across lab and manufacturing segments. Shares hovered near $1,267, with YTD performance around -9% reflecting broader sector pressures but 16% one-year gains. Recent weeks showed modest stability, with analysts maintaining overweight ratings and targets near $1,488 ahead of Q1 earnings. Q4 revenue hit $1.13B, underscoring resilient demand in pharma and food sectors. Influences include steady profitability and global operations, though high valuations prompt caution amid slowing growth signals.
WAT Overview and Recent Performance
Waters Corporation delivers analytical workflow solutions, focusing on liquid chromatography and mass spectrometry for drug discovery and quality control. Trading at about $307, WAT posted YTD returns near 19%, with recent three-month dips offset by Q4 revenue growth to $932M. Market sentiment reflects upcoming May 5 earnings expectations of revenue softness, yet analyst targets average $385. Key drivers include strong LC-MS (liquid chromatography-mass spectrometry) demand, though economic headwinds in China and R&D spending shifts have pressured shares in recent weeks.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the top 25 AI trading bots from over 351 available, selected for superior performance in current market conditions using machine learning strategies across stocks, ETFs, and crypto. These bots showcase annualized returns ranging from +23.53% to +163.10%, win rates of 51.30% to 88.33%, and profit factors up to 11.70, with trade durations from 1 day to 49 days. Diverse styles include swing trading industrials, semiconductor plays, space imaging, and volatility ETFs, often outperforming the S&P 500. Virtual and signal agents adapt to trends like AI infrastructure and gold miners. Explore these high-potential bots to enhance your trading edge.
Head-to-Head Comparison
In business models, BRKR emphasizes advanced imaging and diagnostics, MTD precision weighing, and WAT chromatography, all tied to pharma R&D growth drivers. Recent momentum favors BRKR’s innovation surge, while MTD and WAT offer larger scale with $25B+ market caps versus BRKR’s $5.6B. Risk factors include sector exposure to China slowdowns and capex cycles, with BRKR most sensitive due to lower forward P/E. Valuation contrasts highlight BRKR’s attractiveness, MTD’s premium pricing, and WAT’s balanced metrics. Sentiment leans positive across the board, with analyst upgrades amid biopharma tailwinds, though trade-offs pit BRKR’s upside against peers’ stability.
Tickeron AI Verdict
Tickeron’s AI currently favors MTD for its trend consistency, dominant market position, and resilient profitability in recent market activity. Observable catalysts like strong analyst conviction and lower relative drawdowns position it probabilistically ahead, though BRKR’s value and WAT’s growth potential warrant monitoring post-earnings.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRKR’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s), and WAT’s FA Score reflects 2 green FA rating(s).
- BRKR’s FA Score: 1 green, 4 red.
- MTD’s FA Score: 1 green, 4 red.
- WAT’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRKR’s TA Score shows that 6 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s), and WAT’s TA Score reflects 7 bullish TA indicator(s).
- BRKR’s TA Score: 6 bullish, 4 bearish.
- MTD’s TA Score: 4 bullish, 6 bearish.
- WAT’s TA Score: 7 bullish, 3 bearish.
Price Growth
BRKR (@Medical/Nursing Services) experienced а +17.68% price change this week, while MTD (@Medical Specialties) price change was -17.66% , and WAT (@Medical Specialties) price fluctuated +2.76% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.80%. For the same industry, the average monthly price growth was -1.65%, and the average quarterly price growth was -4.18%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -0.69%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was -7.42%.
Reported Earning Dates
BRKR is expected to report earnings on Aug 05, 2026.
MTD is expected to report earnings on Jul 23, 2026.
WAT is expected to report earnings on Aug 04, 2026.
Industries' Descriptions
@Medical/Nursing Services (-0.80% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-0.69% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BRKR | MTD | WAT | |
| Capitalization | 6.81B | 21.7B | 34.6B |
| EBITDA | 306M | 1.24B | 1.03B |
| Gain YTD | -4.909 | -23.077 | -7.272 |
| P/E Ratio | 74.88 | 25.19 | 44.81 |
| Revenue | 3.46B | 4.03B | 3.17B |
| Total Cash | 133M | 66.9M | 588M |
| Total Debt | 1.67B | 2.15B | 1.49B |
BRKR | MTD | WAT | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 51 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 99 Overvalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 81 | |
SMR RATING 1..100 | 91 | 3 | 33 | |
PRICE GROWTH RATING 1..100 | 46 | 65 | 51 | |
P/E GROWTH RATING 1..100 | 5 | 67 | 22 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BRKR's Valuation (70) in the Medical Specialties industry is in the same range as WAT (77) and is in the same range as MTD (99). This means that BRKR's stock grew similarly to WAT’s and similarly to MTD’s over the last 12 months.
WAT's Profit vs Risk Rating (81) in the Medical Specialties industry is in the same range as BRKR (100) and is in the same range as MTD (100). This means that WAT's stock grew similarly to BRKR’s and similarly to MTD’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is in the same range as WAT (33) and is significantly better than the same rating for BRKR (91). This means that MTD's stock grew similarly to WAT’s and significantly faster than BRKR’s over the last 12 months.
BRKR's Price Growth Rating (46) in the Medical Specialties industry is in the same range as WAT (51) and is in the same range as MTD (65). This means that BRKR's stock grew similarly to WAT’s and similarly to MTD’s over the last 12 months.
BRKR's P/E Growth Rating (5) in the Medical Specialties industry is in the same range as WAT (22) and is somewhat better than the same rating for MTD (67). This means that BRKR's stock grew similarly to WAT’s and somewhat faster than MTD’s over the last 12 months.
| BRKR | MTD | WAT | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 62% | 1 day ago 67% | 1 day ago 56% |
| Stochastic ODDS (%) | 1 day ago 72% | 1 day ago 62% | 1 day ago 69% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 59% | 1 day ago 64% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 67% | 1 day ago 58% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 63% | 1 day ago 65% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 66% | 1 day ago 61% |
| Advances ODDS (%) | 6 days ago 69% | 8 days ago 63% | 6 days ago 64% |
| Declines ODDS (%) | 15 days ago 71% | 1 day ago 63% | 10 days ago 63% |
| BollingerBands ODDS (%) | 1 day ago 71% | 1 day ago 74% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 59% | 1 day ago 68% | 1 day ago 58% |
Advertisement
BRKR and
Correlation & Price change
A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.
| Ticker / NAME | Correlation To BRKR | 1D Price Change % | ||
|---|---|---|---|---|
| BRKR | 100% | +3.37% | ||
| A - BRKR | 78% Closely correlated | +1.29% | ||
| MTD - BRKR | 75% Closely correlated | -0.56% | ||
| WAT - BRKR | 68% Closely correlated | +1.19% | ||
| RVTY - BRKR | 68% Closely correlated | +0.35% | ||
| TMO - BRKR | 66% Loosely correlated | +1.48% | ||
More | ||||
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | -0.56% | ||
| A - MTD | 76% Closely correlated | +1.29% | ||
| RVTY - MTD | 73% Closely correlated | +0.35% | ||
| TMO - MTD | 70% Closely correlated | +1.48% | ||
| DHR - MTD | 68% Closely correlated | -0.16% | ||
| BRKR - MTD | 67% Closely correlated | +3.37% | ||
More | ||||